A Randomized, Placebo-Controlled, Double-Blind, Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel, Abraxane®) With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Paclitaxel (Primary) ; Mifepristone
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 06 Mar 2018 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.
- 06 Mar 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Feb 2019.
- 10 Jun 2017 Biomarkers information updated